MP
Therapeutic Areas
Progentec Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| aiSLE® DX Flare Risk Index | Systemic Lupus Erythematosus (SLE) | Commercial |
| aiSLE® DX Disease Activity Index | Systemic Lupus Erythematosus (SLE) | Commercial |
| OASIS Study (Digital Biomarkers) | Systemic Lupus Erythematosus (SLE) | Clinical Study |
| MS Biomarker Development | Multiple Sclerosis (MS) | Pre-clinical/R&D |